Recent investigations haveing on these novel peptides, a distinct category of molecules demonstrating significant capability for targeting multiple condition pathways. Distinct from traditional drug approaches, these peptides provide enhanced specificity and lesser side reactions, allowing them a particularly desirable option for next-generation dr